Bladder cancer, Transitional cell cancer
Results
Phase 2/3
This trial looked at lapatinib for advanced bladder cancer. It was for people:
with transitional cell cancer (TCC) of the lining of the urinary system ()
whose cancer had large amounts of 2 proteins called HER1 or
Cancer Research UK supported this trial.
Recruitment start: 27 January 2009
Recruitment end: 15 January 2014
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Prof Thomas Powles
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Queen Mary University of London
This is Cancer Research UK trial number CRUKE/09/002.
Last reviewed: 04 Jul 2017
CRUK internal database number: 1854
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
